Amid a slew of secondary equity raisings and at least two planned IPOs, the biotech sector is ending a difficult year on a brighter note.
Good morning! Here’s everything you need to know before the ASX flings open its doors and begins trading today.
Uvre reports strong rock chip sample results from its Waitekauri and Oturehua gold projects in New Zealand.
October was rough for Aussie tech, with Xero and WiseTech dragging the XIJ down 8%. But despite the red ink a new crop of stars still came to the fore.
The ASX 200 Health Care Index fell 4.83% in October and is now deep in red territory for 2025 as heavy CSL fall weighs on sector.
